Rongbei Liu

663 total citations
19 papers, 439 citations indexed

About

Rongbei Liu is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Rongbei Liu has authored 19 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Genetics and 4 papers in Surgery. Recurrent topics in Rongbei Liu's work include Inflammatory Bowel Disease (6 papers), Gut microbiota and health (3 papers) and Eosinophilic Esophagitis (2 papers). Rongbei Liu is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Gut microbiota and health (3 papers) and Eosinophilic Esophagitis (2 papers). Rongbei Liu collaborates with scholars based in China and United States. Rongbei Liu's co-authors include Qian Cao, Yu Zhang, Yi‐yuan Li, Jin Jin, Xin-tao Mao, Jiang-yan Zhong, Ke-qi Fan, Peng Xiao, Yuan Zhao and Renjie Chai and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and Immunity.

In The Last Decade

Rongbei Liu

17 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rongbei Liu China	9	223	113	71	63	62	19	439
Kaline Arnauts Belgium	13	215 1.0×	79 0.7×	38 0.5×	91 1.4×	43 0.7×	29	502
Lingfen Xu China	11	159 0.7×	93 0.8×	69 1.0×	35 0.6×	20 0.3×	24	424
Naoko Tachibana Japan	8	229 1.0×	97 0.9×	33 0.5×	57 0.9×	20 0.3×	14	388
Robert D. Thurston United States	8	187 0.8×	119 1.1×	46 0.6×	48 0.8×	58 0.9×	8	484
Lauren C. Binge Australia	7	320 1.4×	113 1.0×	30 0.4×	56 0.9×	20 0.3×	8	535
Vahid Chaleshi Iran	12	157 0.7×	92 0.8×	31 0.4×	83 1.3×	24 0.4×	41	436
Joerg-Dieter Schulzke Germany	6	164 0.7×	74 0.7×	23 0.3×	42 0.7×	68 1.1×	6	385
Navdha Mittal United States	8	256 1.1×	122 1.1×	43 0.6×	65 1.0×	55 0.9×	9	569
Claudia Maresca Italy	8	178 0.8×	46 0.4×	20 0.3×	37 0.6×	34 0.5×	17	334
Pyeung-Hyeun Kim South Korea	10	276 1.2×	125 1.1×	38 0.5×	47 0.7×	15 0.2×	12	513

Countries citing papers authored by Rongbei Liu

Since Specialization

Citations

This map shows the geographic impact of Rongbei Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongbei Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongbei Liu more than expected).

Fields of papers citing papers by Rongbei Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongbei Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongbei Liu. The network helps show where Rongbei Liu may publish in the future.

Co-authorship network of co-authors of Rongbei Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Rongbei Liu. A scholar is included among the top collaborators of Rongbei Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongbei Liu. Rongbei Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Xiao, Peng, Zhehang Chen, Wenhao Xia, et al.. (2025). Targeting hyaluronan synthesis enhances the therapeutic effectiveness of biologics in inflammatory bowel disease. JCI Insight. 10(1).

Liu, Rongbei, et al.. (2025). Development and Validation of a Clinical Decision Support Tool to Predict Disease Progression in Crohn’s Disease Treated with Ustekinumab. Journal of Clinical Medicine. 14(22). 7919–7919.

Xiao, Peng, Zhou Zhang, Ke Guo, et al.. (2024). Butyrate Prevents the Pathogenic Anemia‐Inflammation Circuit by Facilitating Macrophage Iron Export. Advanced Science. 11(12). e2306571–e2306571. 17 indexed citations

Xiang, Xiaoxia, et al.. (2024). Differences of clinical phenotype between familial and sporadic Crohn’s disease in East China. International Journal of Colorectal Disease. 39(1). 107–107. 2 indexed citations

Chen, Xuejie, Wenya Liu, Yue Yang, et al.. (2024). Serum Microcystin-LR Levels Linked with Risk of Inflammatory Bowel Disease: A Matched Case-Control Study in China. Environment & Health. 2(7). 453–464. 4 indexed citations

Qi, Jing, Guangcong Ruan, Ping Yi, et al.. (2023). Development and validation of a deep learning-based approach to predict the Mayo endoscopic score of ulcerative colitis. Therapeutic Advances in Gastroenterology. 16. 1108353921–1108353921. 6 indexed citations

Liu, Rongbei, Jing Hu, Jian Tang, et al.. (2023). Risk of Tuberculosis and Hepatitis B Reactivation in Patients With Crohn’s Disease on Ustekinumab: A Nationwide Real-World Study. Inflammatory Bowel Diseases. 30(1). 45–52. 6 indexed citations

Zhang, Yu, Chaohui Wang, Zhou Zhang, et al.. (2023). Epithelial CRL4DCAF2 Is Critical for Maintaining Intestinal Homeostasis Against DSS-Induced Colitis by Regulating the Proliferation and Repair of Intestinal Epithelial Cells. Digestive Diseases and Sciences. 69(1). 66–80. 2 indexed citations

Liu, Rongbei, Wenping Li, Tao Huang, et al.. (2022). XAF1 prevents hyperproduction of type I interferon upon viral infection by targeting IRF7. EMBO Reports. 24(1). e55387–e55387. 11 indexed citations

10.

Zhu, Xiao, Bule Shao, Rongbei Liu, et al.. (2021). Reasons and Factors Contributing to Chinese Patients’ Preference for Ustekinumab in Crohn’s Disease: A Multicenter Cross-Sectional Study. Frontiers in Pharmacology. 12. 736149–736149. 4 indexed citations

11.

Mao, Xin-tao, Yi‐yuan Li, Dandan Liu, et al.. (2021). Multiomics analyses reveal a critical role of selenium in controlling T cell differentiation in Crohn’s disease. Immunity. 54(8). 1728–1744.e7. 135 indexed citations

12.

Xiao, Peng, Yu Zhang, Mingzhu Zheng, et al.. (2019). Phosphatase Shp2 exacerbates intestinal inflammation by disrupting macrophage responsiveness to interleukin-10. The Journal of Experimental Medicine. 216(2). 337–349. 70 indexed citations

13.

Zhang, Yu, Rongbei Liu, Qian Cao, et al.. (2019). USP16-mediated deubiquitination of calcineurin A controls peripheral T cell maintenance. Journal of Clinical Investigation. 129(7). 2856–2871. 43 indexed citations

14.

Su, Tingting, Rongbei Liu, Allen Lee, et al.. (2018). Altered Intestinal Microbiota with Increased Abundance of Prevotella Is Associated with High Risk of Diarrhea-Predominant Irritable Bowel Syndrome. Gastroenterology Research and Practice. 2018. 1–9. 94 indexed citations

15.

Fan, Ke-qi, Fei Wang, Yiyuan Li, et al.. (2018). CRL4DCAF2 is required for mature T-cell expansion via Aurora B-regulated proteasome activity. Journal of Autoimmunity. 96. 74–85. 10 indexed citations

16.

Liu, Rongbei, Mengyu Wang, Lizhi Zhang, et al.. (2018). The clinicopathologic features of chronic active Epstein-Barr virus infective enteritis. Modern Pathology. 32(3). 387–395. 24 indexed citations

17.

Su, Tingting, Rongbei Liu, Yanqin Long, et al.. (2018). 1-Day or 5-Day Fecal Samples, Which One is More Beneficial to be Used for DNA-Based Gut Microbiota Study. Current Microbiology. 75(3). 288–295. 1 indexed citations

18.

Zhang, Yu, Rongbei Liu, Mengyu Wang, et al.. (2017). Case report of a pair of siblings with cryptogenic multifocal ulcerating stenosing enteritis. Medicine. 96(32). e7527–e7527. 9 indexed citations

19.

Liu, Rongbei, Hua Chu, Fei Xu, & Shujie Chen. (2016). Esophageal cancer diagnosed by high-resolution manometry of the esophagus: A case report. Oncology Letters. 11(5). 3131–3134. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact